IL-18 and IL-12 Decrease ABCA1 Via IL-18R/NF-κB
terol and phospholipids onto apolipoprotein A-I (apoA-I) to form nascent HDL. 8 Mutations in ABCA1 cause Tangier disease, which is characterized by very low levels of serum HDL cholesterol, rapid catabolism of apoA-I, severe cholesteryl ester accumulation in peripheral tissues, and a high risk of development of coronary heart disease. 9 Transcription of ABCA1 is directly induced by liver X receptor (LXR), which can form a heterodimer with retinoid X receptor (RXR), and which binds to response elements in the ABCA1 promoter and the first intron when activated by agonists such as oxysterols. 10 Other factors including cytokines, bacterial lipopolysaccharide (LPS) and eicosapentaenoic acid have been reported to modulate ABCA1 expression. 11, 12 The activity of IL-18 is mediated by the IL-18 receptor (IL-18R) complex consisting of the ligand-binding chain, termed 'IL-18Rα', and a signaling chain, termed 'IL-18Rβ'. After binding to the IL-18Rα chain, IL-18 induces the formation of the heterodimeric complex with the IL-18Rβ chain and subsequently activates IL-1 receptor-associated kinase (IRAK) and tumor necrosis factor (TNF) receptor-associated factor 6 (TRAF-6). 13 These activated kinases eventually result in the translocation of nuclear factor-κB (NF-κB) from cytoplasm to nucleus. 14, 15 Recently, our group and others have shown that ABCA1 levels are regulated by inflammatory stimuli including IFN-γ, IL-1β, LPS and TNF-α in an LXR-dependent orindependent manner. 16- 19 Whether exposure of cells to IL-18 and/or IL-12 affects ABCA1 expression, however, is unknown.
In the present study, we demonstrated that the IL-18R/NF-κB signaling pathway but not the LXRα pathway plays an important role in the effects of IL-18 and IL-12 on ABCA1 expression and on cellular cholesterol efflux.
Methods

Cell Culture and Foam Cell Formation Evaluated on Oil Red O Staining
Human THP-1 cells (American Type Culture Collection (ATCC), Manassas, VA, USA) were seeded into 6-well plates at 1.0×10 6 cells/well in RPMI1640 medium containing 10% fetal bovine serum (FBS), 20 IU/ml penicillin, 20 μg/ml streptomycin and maintained at 37°C in a humidified atmosphere of 5% CO2. The cells were differentiated into macrophages by the addition of 100 ng/ml phorbol 12-myristate 13-acetate for 72 h. Macrophages were transformed into foam cells by incubation with or without 50 mg/ml oxidized low density lipoprotein in serum-free RPMI1640 medium containing 0.3% bovine serum albumin for 48 h. Cultured macrophages were then washed once with PBS and fixed in 4% paraformaldehyde-PBS for 10 min. After rinsing with 60% isopropanol, macrophages were stained with 0.3% Oil Red O in 60% isopropanol for 10 min and then washed with 60% isopropanol again, followed by counterstaining with hematoxylin for 3 min. After copious washing with water, macrophages were photographed with a microscope at ×400 magnification ( Figure S1 ).
Male C57BL/6J mice were purchased from the Jackson Laboratory (Bar Harbor, ME, USA). Peritoneal macrophages were obtained from mice injected i.p. with thioglycollate. Bone marrow-derived macrophages were isolated and cultured in DMEM/10% FBS supplemented with macrophage-colony stimulating factor (20 ng/ml) and antibiotics for 5-9 days before the experiment. 
Transfection of Small
Statistical Analysis
Data are expressed as mean ± SD. Results were analyzed on 1-way ANOVA and Student's t-test, using SPSS 13.0. Statistical significance was set at P<0.05.
Materials, real-time quantitative polymerase chain reaction (PCR), western blot, cellular cholesterol efflux experiments, high performance liquid chromatography and enzyme-linked immunosorbent assay (ELISA) are described in Data S1.
Results
Effects of IL-18 and IL-12 on Expression of ABCA1
To investigate the role of IL-18 and IL-12 on the regulation of ABCA1, we examined the mRNA and protein levels of ABCA1 in IL-18-and/or IL-12-treated THP-1 macrophagederived foam cells on real-time quantitative PCR and western blot assays. As shown in Figures 1A-D , treatment with IL-18 or IL-12 alone did not affect the mRNA and protein levels of ABCA1. Simultaneous incubation of IL-18 and IL-12, however, dramatically decreased ABCA1 expression in a timedependent manner (Figures 1E,F) . Similar effects were observed in THP-1 cells, THP-1 macrophages, murine peritoneal macrophages and murine bone marrow-derived macrophages ( Figure S2 ).
ABCA1 plays a critical role in regulating cellular cholesterol homeostasis and in RCT by mediating cholesterol efflux onto apoA-I. Thus, we examined whether IL-18 and IL-12 affected cholesterol content and cholesterol efflux in THP-1 macrophage-derived foam cells. As expected, cholesterol efflux from cells treated with IL-18 and IL-12 was significantly reduced ( Figure 1G) . Consistently, cellular cholesterol content in IL-18/IL-12-treated cells was increased (Table S1 ). These findings demonstrate that IL-18 and IL-12 together can decrease ABCA1 expression and cellular cholesterol efflux in THP-1 macrophage-derived foam cells.
Effect of IL-18 or IL-12 on Expression of Each Other's Receptor
Next, we analyzed whether the 2 cytokines influenced the expression of each other's receptor. As shown in Figures 2A,B , the increased levels of IL-18R mRNA and protein were observed as early as 4 h after IL-12 treatment and reached a maximum at 16 h in THP-1 macrophage-derived foam cells. In sharp contrast, incubation of cells with IL-18 did not alter IL-12R expression (Figures 2C,D) . YU XH et al. The mRNA levels of ABCA1 were assayed on real-time quantitative polymerase chain reaction (PCR). (B,D) Protein levels of ABCA1 were assayed on western blot. (E,F) Cells were pretreated with IL-12 (2 ng/ml) for 12 h and then incubated with IL-18 (20 ng/ml) for an additional 24 h, or simultaneously incubated with IL-18 (20 ng/ml) and IL-12 (2 ng/ml) for the indicated times. The expression levels of ABCA1 mRNA and protein were analyzed on real-time quantitative PCR and western blot, respectively. (G) Cells were simultaneously incubated with IL-18 (20 ng/ml) and IL-12 (2 ng/ml) for the indicated times. Cellular cholesterol efflux was analyzed using a liquid scintillation counting method. All data are mean ± SD from 3 independent experiments, each performed in triplicate. *P<0.05 vs. control group. IL-18 and IL-12 Decrease ABCA1 Via IL-18R/NF-κB
IL-12-Induced IL-18R Expression Is Mediated by STAT3
IL-18R expression has been reported to be controlled by STAT3. 20 In human peripheral blood monocyte-derived dendritic cells, STAT3 has been demonstrated to be activated by IL-12. 21 Therefore, THP-1 macrophage-derived foam cells were treated with IL-12, and phosphorylation of STAT3 was determined. We found that STAT3 was phosphorylated at 10 min after addition of IL-12. The phosphorylation was further enhanced up to 30 min ( Figure 3A) . Because phosphorylated STATs dimerize and translocate into the nucleus to initiate transcription, 22 we examined the nuclear translocation of STAT3 in IL-12-stimulated cells. The level of STAT3 in the nucleus was increased in a time-dependent manner after addition of IL-12 ( Figure 3B ). The role of STAT3 was further defined using siRNA transfection. STAT3 protein levels in THP-1 macrophage-derived foam cells transfected with STAT3 siRNA were suppressed by 80%, compared with cells transfected with a scrambled siRNA ( Figure 3C ). The ability of IL-12 to induce IL-18R expression was significantly impaired by siRNA of STAT3 ( Figures 3D,E) , suggesting that STAT3 plays an important role in IL-12-induced IL-18R expression. 
Requirement of IL-18R But Not IL-12R for IL-18/IL-12-Induced Downregulation of ABCA1
To address whether the downregulation of ABCA1 expression by IL-18 and IL-12 was mediated through IL-18R and/or IL-12R, the effects of IL-18R and IL-12R siRNA were examined. Treatment of IL-18R and IL-12R with siRNA reduced IL-18R and IL-12R protein levels by 85% and 78%, respectively ( Figure 4A ). Knockdown of IL-18R completely abolished the influences of IL-18 plus IL-12 on ABCA1 expression and cellular cholesterol efflux (Figures 4B-D) , whereas IL-12R siRNA did not have these effects (Figures 4E-G) . Collectively, these findings demonstrate that IL-18R but not IL-12R is required for IL-18/IL-12's action on ABCA1.
NF-κB Is Involved in the Downregulation of ABCA1 by IL-18 and IL-12
Because activation of NF-κB is the dominant consequence of signaling through IL-18R, 14,23 we wanted to address whether the suppressive effect of IL-18 and IL-12 on ABCA1 expression required activation of NF-κB. To do so, THP-1 macrophage-derived foam cells were stimulated with IL-18 and IL-12, and the levels of p65, the transcriptionally active subunit of NF-κB, were determined in the nuclear extract using western blot. Figure 5A shows that IL-18 together with IL-12 significantly increased NF-κB p65 levels in the nucleus, indicating involvement of NF-κB in the IL-18/IL-12-induced effect. To further confirm this possibility, we treated cells with NF-κB siRNA or N-tosyl-L phenylalanyl-chloromethyl ketone (TPCK), an inhibitor of NF-κB activity. Treatment with IL-18 and IL-12 Decrease ABCA1 Via IL-18R/NF-κB siRNA for NF-κB downregulated NF-κB p65 levels by 81% ( Figure 5B ) and significantly impaired the effects of IL-12 plus IL-18 on ABCA1 expression and cholesterol efflux (Figures 5C-E) . Similar results were obtained in the presence of TPCK (Figures 5F-H) . In addition, TPCK stimulation partially but significantly reversed IL-18/IL-12-induced increase in cellular cholesterol content (Table S2 ). Taken together, the present findings demonstrate that inhibition of NF-κB can partially attenuate the accumulation of cellular cholesterol caused by IL-18 and IL-12, and strongly suggest the involvement of NF-κB in IL-18/IL-12's action on ABCA1 expression.
NF-κB Decreases ABCA1 Expression Through ZNF202 and IFN-γ
Accumulating evidence shows that ZNF202 is a transcriptional repressor of ABCA1. 24 To define whether ZNF202 is associated with the effects of IL-18 and IL-12, THP-1 macrophage-derived foam cells incubated with IL-18 plus IL-12 were treated with or without NF-κB siRNA. IL-18 plus IL-12 remarkably increased ZNF202 levels, which were blocked by NF-κB siRNA ( Figure 6A) . We further treated cells with ZNF202 siRNA directly and found that siRNA for ZNF202 efficiently reduced ZNF202 expression by 85% ( Figure 6B ) and significantly reversed IL-18/IL-12-induced suppression of ABCA1 (Figures 6C,D) . These findings demonstrate that 
ZNF202 is involved in the downregulation of ABCA1 by IL-18 and IL-12.
It has already been reported that IL-18 and IL-12 synergistically produce IFN-γ, which can downregulate ABCA1. 5, 25 Therefore, we speculated on the involvement of IFN-γ in downregulation of ABCA1 expression by IL-18 and IL-12. To investigate this, we first examined the concentration of IFN-γ using ELISA after incubation of THP-1 macrophage-derived foam cells with IL-18, IL-12 and/or NF-κB siRNA. We found that IL-18 or IL-12 alone did not induce production of IFN-γ. In contrast, IL-18 combined with IL-12 induced IFN-γ production, which was blocked by NF-κB siRNA ( Figure 6E) . Next, we investigated the effect of IFN-γ siRNA on IL-18/IL-12-mediated downregulation of ABCA1 expression. IFN-γ siRNA inhibited IFN-γ secretion by 82% ( Figure 6F) and significantly impaired the IL-18/IL-12-induced effect on ABCA1 expression (Figures 6G,H) . Overall, these results indicate that IFN-γ plays an important role in IL-18/IL-12-induced downregulation of ABCA1 expression.
LXRα Is Not Involved in the Downregulation of ABCA1 by IL-18 and IL-12
ABCA1 is the target gene of LXRα. 26 To investigate whether LXRα was involved in IL-18/IL-12-induced effect, we first analyzed the impact of IL-18 and IL-12 on LXRα expression. IL-18 and IL-12 stimulation did not alter LXRα expression (Figures 7A,B) . The activity of LXRα, however, is regulated not only by its expression. Thus, we examined the LXRα activity directly using an LXR response element (LXRE)-driven luciferase reporter assay. THP-1 macrophage-derived foam cells were transfected with the LXRE-driven luciferase-reporter vector, then treated with IL-18 and IL-12. The luciferase activity was measured. Addition of IL-18 and IL-12 had no effect on the LXRE luciferase activity (Figure 7C) , suggesting that IL-18/IL-12 treatment did not significantly affect LXR activity. To further investigate the role of LXR on ABCA1 expression under IL-18 and IL-12 treatment, we used the luciferase reporter assay to measure the promoter activity of ABCA1 directly. Wild-type ABCA1 promoter starting from -928 that contains the direct repeat 4 (DR4) between -70 and -55 bp of ABCA1 promoter was placed in the luciferase re- IL-18 and IL-12 Decrease ABCA1 Via IL-18R/NF-κB porter vector (pABCA1-Luc). DR4 is a sterol-responsive element and is regulated by LXR and RXR heterodimers. A similar construct containing a mutant ABCA1 promoter, in which the DR4 site was mutated, was also made (pABCA1-DR4M-luc). We transfected cells with pABCA1-Luc or pABCA1-DR4M-luc. As shown in Figure 7D , IL-18 and IL-12 significantly reduced the promoter activities of both wildtype and mutant ABCA1 promoter. Together, these findings strongly suggest that IL-18 plus IL-12 downregulate ABCA1 expression in an LXRα-independent manner.
Discussion
Both in vivo and in vitro studies have indicated prominent roles for IL-18 and Il-12 in the pathogenesis of atherosclerosis. Macrophage-derived cholesteryl ester-rich foam cells develop within the arterial wall as a result of excessive internalization of lipoproteins, which subsequently promotes early atherosclerotic plaque formation. Maintenance of cellular cholesterol homeostasis is important for normal human physiology. ABCA1 mediates the secretion of cellular free cholesterol and phospholipids to lipid-free or lipid-poor apoA-I in order to form HDL, playing a central role in maintaining cholesterol homeostasis and anti-atherogenesis. 27 In the present study we have demonstrated, for the first time, that IL-18 and IL-12, 2 key pro-atherogenic molecules, synergistically suppress ABCA1 gene and protein expression as well as cellular cholesterol efflux in THP-1 macrophage-derived foam cells. The IL-18R/NF-κB pathway but not LXRα mediates the downregulation of ABCA1 by IL-18 and IL-12, which may play an important role in the alteration of lipid metabolism during inflammatory disease.
Recent studies clearly highlight the close link between inflammation and cholesterol homeostasis, in which inflammatory mediators alter the expression of key molecules regulating lipid metabolism. 28 LPS and cytokines have been reported to decrease ABCA1 expression and cholesterol efflux from cholesterol-loaded macrophages. 29, 30 In the inflammatory condition, the breakdown of the homeostatic mechanism aggravates the lesions of artherosclerosis. In particular, IL-18 and IL-12 are cytokines involved in infection and inflammation. In the current study, the data showed that IL-18 in combination with IL-12, but not IL-18 or IL-12 alone, significantly decreased ABCA1 expression and cellular cholesterol efflux. Thus the downregulation of ABCA1 may be one of the mechanisms by which IL-18 and IL-12 contribute to atherosclerosis. Besides being produced by macrophages, ABCA1 is in metabolically active tissues, such as liver, intestine, and kidney, and also participates in the regulation of the plasma lipid levels. Thus the alteration of ABCA1 expression by the inflammatory pathway has vast implications.
IL-18 acts by binding to the heterodimeric IL-18R complex. A recent report supports the notion that IL-18 is a weak activator in most cell types and needs a costimulant that increases its receptor expression. 31 The present study demonstrated that incubation of THP-1 macrophage-derived foam cells with IL-12 clearly increased the expression of both IL-18R mRNA and protein, while IL-18 treatment did not alter the levels of IL-12R, which is consistent with previous findings that IL-18R expression is upregulated by IL-12 in T cells, Th1 cells, and B cells. 32 Other inflammatory cytokines overexpressed in human atheroma, such as IL-1β and TNF-α, 33,34 also enhance the expression of IL-18R on NK cells and T cells, thereby increasing its responsiveness to IL-18. 35 IL-12 is known to activate STAT3, which can enhance IL-18R gene transcription by binding to its promoter sequence. 20, 21 In the present study we have demonstrated that STAT3 plays a crucial role in IL-12-induced IL-18R expression. In addition, we found that IL-18R siRNA almost completely reversed the decreases in ABCA1 expression and cellular cholesterol efflux induced by IL-18 and IL-12, while IL-12R siRNA had no such effects. IL-18 binding protein (IL-18BP) binds to IL-18 with a high affinity and neutralizes its biological activities, thereby resulting in an inhibition of IL-18 binding to IL-18R. 36 It was recently reported that use of a plasmid encoding a soluble, recombinant IL-18BP in apoE knock-out mice led to smaller atherosclerotic lesions after a 9-week treatment period. 37 In another study, Th1 cells and NK cells derived from IL-18Rα-deficient mice had the impaired IL-18 signaling. 38 Taken together, these data suggest that IL-12 activates STAT3, induces increase of IL-18R, and sequentially downregulates ABCA1 expression.
NF-κB is a central mediator of gene expression induced by pro-inflammatory and pro-atherogenic stimuli, including inflammatory cytokines, oxidative stress, and bacterial products. 39, 40 It is also a critical regulator involved in the cross-talk between the inflammatory pathway and nuclear receptor signaling. Numerous studies have shown that IL-18R can activate NF-κB in many cell types. 13, 15 Consistently, it was found that combined stimulation with IL-18 and IL-12 strongly elevated the levels of NF-κB p65 in the nucleus, indicating that IL-18 and IL-12 together can activate NF-κB in THP-1 macrophagederived foam cells. Furthermore, NF-κB siRNA or TPCK, a potent inhibitor of NF-κB activation by inhibiting I-κB phosphorylation, partially but significantly prevented the decreases of IL-18/IL-12-induced ABCA1expression and cellular cholesterol efflux, which suggests that besides the involvement of NF-κB activation as the mechanism in this process, another pathway may exist as well. A recent study by Baranova et al also demonstrated that the inhibitory effect of LPS on scavenger receptor B1 and ABCA1 in RAW 264.7 cells depends on NF-κB. 18 Because the direct binding site of NF-κB on the ABCA1 promoter has yet to be found, NF-κB may regulate ABCA1 indirectly through some intermediate mechanism.
ZNF202 is a transcriptional repressor of ABCA1 by binding to GnT repeats within the ABCA1 promoter. 24 IFN-γ has been demonstrated to have a variety of pro-atherogenic effects, including inhibition of ABCA1 expression. 25 Here we report that IL-18 and IL-12 can increase the levels of ZNF202 and IFN-γ by the NF-κB pathway. Moreover, siRNA for ZNF202 and IFN-γ significantly blocked IL-18/IL-12's action on ABCA1, suggesting that NF-κB decreases ABCA1 expression via ZNF202 and IFN-γ. Further studies are needed, however, to clarify the exact roles of these proteins in IL-18/IL-12-mediated downregulation of ABCA1 expression.
LXRα can upregulate the expression of ABCA1 by forming heterodimers with RXR. 41 Recent studies demonstrated that LXR synthetic agonists T0901317 elevated ABCA1 gene and protein levels in the aorta, liver, and small intestine of apoE knock-out mice and increased cholesterol efflux from peritoneal macrophages. 42 In mouse kidney and in HK-2 cells, LPS, IL-1β, and TNF-α suppress ABCA1 by downregulating LXRα, 11 but several lines of evidence have shown that LXRα is not involved in the suppression of ABCA1 by inflammatory mediators in macrophages. 18,29, 30 In the present study we report that downregulation of ABCA1 by IL-18 and IL-12 is mediated through an LXRα-independent mechanism. First, treatment of THP-1 macrophage-derived foam cells with IL-18 and IL-12 did not decrease LXRα expression. Second, IL-18 and IL-12 stimulation did not alter the activity of the LXREdriven luciferase reporter. Finally, the deletion of the DR4 element from the promoter of ABCA1 did not reverse the effect of IL-18 and IL-12. Perhaps this discrepancy might be due to different cell types. The kidneys belong to metabolically active tissues, thereforeo the metabolic nuclear receptors are more active. In inflammatory cells, such as monocytes and macrophages, nuclear factors (eg, NF-κB) that are involved in inflammation are more sensitive to an inflammatory mediator.
In summary, the present study demonstrates that the proinflammatory cytokines IL-18 and IL-12 together can downregulate ABCA1 expression, decrease cellular cholesterol efflux and promote accumulation of lipid in THP-1 macrophagederived foam cells. The IL-18R/NF-κB pathway, but not LXRα, contributes to the IL-18/IL-12-induced effects (Figure 8) . The present findings provide a novel explanation for the pro-atherogenic actions of IL-18/IL-12 and a possible molecular therapeutic target to reduce the risk of atherosclerosis. 
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